HCN News & Notes

Massachusetts Prostate Cancer Coalition to Present Virtual Symposium on May 17

BOSTON — The Massachusetts Prostate Cancer Coalition (MPCC) will bring together today’s leading and distinguished physicians and medical professionals to share the latest in diagnosis, treatment, and research at the 2024 Massachusetts Prostate Cancer Symposium. The virtual event will be held on Friday, May 17 from 8 to 11:30 a.m. The event is free and open to the public. Click here for full program information and to register.

With sessions on survivorship, genetic testing, diet and lifestyle, biochemical recurrence, AI and research, and naturopathic functional medicine, the symposium will present innovative dialogues, understanding, and state-of-the-art research for those who are diagnosed or at risk, survivors, and caregivers.

“For more than 20 years, MPCC has been in the forefront of providing clear and user-friendly information on the diagnosis, treatment, and research of prostate cancer for men, their families, and their caregivers,” said Allen Snyder III, MPCC chairman and prostate-cancer survivor. “This year’s symposium addresses the most current information on the use of AI, the decisions around genetic testing, how to survive and thrive after diagnosis, and much more.”

Presenters at the MPCC Symposium are leading experts, researchers, and professionals dedicated to enhancing and advancing positive results for individuals affected by prostate cancer. The event acknowledges the importance of research and of sharing the latest information to improve outcomes.

“After a prostate-cancer diagnosis, a patient can become a thriver, not only a survivor,” said Dr. Geo Espinosa, clinical assistant professor, NYU Langone Health, Department of Urology. “In other words, they have an opportunity to make better lifestyle choices that help them have improved overall health better than before their diagnosis.”